← Teladoc Health, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income (Loss) Attributable to Parent | ($74.2m) | ($106.8m) | ($97.1m) | ($98.9m) | ($485.1m) | ($428.8m) | ($13.7b) | ($220.4m) | ($1.0b) | ($200.3m) | |
| Net Income (Loss) Available to Common Stockholders, Basic | ($74.2m) | — | — | — | — | — | — | — | — | — | |
| Depreciation, Depletion and Amortization | $8.3m | $19.1m | $35.6m | $39.0m | $69.5m | $204.2m | $256.0m | — | — | — | |
| Depreciation | $2.2m | $3.8m | $4.1m | $3.4m | $4.8m | $8.9m | $11.4m | — | — | — | |
| Amortization of Intangible Assets | $6.1m | $15.3m | $31.5m | $35.6m | $64.7m | $195.3m | $244.6m | $325.9m | $363.4m | $350.8m | |
| Capitalized Computer Software, Amortization | — | — | — | — | — | — | $46.1m | $83.0m | $133.0m | $167.6m | |
| Depreciation, Nonproduction | — | — | — | — | — | — | — | $11.1m | $10.2m | $13.3m | |
| Deferred Income Tax Expense (Benefit) | $510k | ($591k) | ($1.9m) | ($10.9m) | ($90.5m) | $41.0m | ($7.8m) | ($1.9m) | ($1.1m) | ($41.4m) | |
| Share-based Payment Arrangement, Noncash Expense | $7.7m | $30.6m | $43.8m | $66.7m | $475.5m | $302.6m | $217.9m | $201.6m | $146.0m | $80.4m | |
| Share-based Payment Arrangement, Expense | $7.7m | $30.6m | $43.8m | $66.7m | $475.5m | $302.6m | $217.9m | $201.6m | $146.0m | $80.4m | |
| Goodwill and Intangible Asset Impairment | — | — | — | — | — | $0 | — | — | — | — | |
| Goodwill, Impairment Loss | $0 | $0 | $0 | $0 | $0 | — | $13.4b | $0 | $790.0m | $71.8m | |
| Impairment of Intangible Assets, Finite-lived | — | — | — | — | — | — | — | $0 | — | — | |
| Share-based Payment Arrangement, Expensed and Capitalized, Amount | — | — | — | — | — | — | — | $221.0m | $158.7m | $88.0m | |
| Gain (Loss) on Disposition of Assets | — | — | $5.5m | $0 | $0 | — | — | — | — | — | |
| Gain (Loss) on Extinguishment of Debt | — | — | — | — | ($9.1m) | ($43.7m) | $0 | $0 | — | — | |
| Income Tax Expense (Benefit) | $510k | ($225k) | $118k | ($10.6m) | ($90.9m) | $44.1m | ($3.8m) | $760k | $7.6m | ($35.2m) | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $23.8m | $19.7m | |
| Other Nonoperating Income (Expense) | — | — | — | — | — | $5.1m | ($859k) | $4.4m | ($6.0m) | $10.4m | |
| Changes in operating assets and liabilities: | |||||||||||
| Additional Financial Items | |||||||||||
| Increase (Decrease) in Accounts Receivable | $2.9m | $3.7m | $10.9m | $15.9m | $21.1m | $17.5m | $61.6m | $10.3m | $375k | ($25.1m) | |
| Increase (Decrease) in Inventories | — | — | — | — | $24.7m | $19.5m | ($14.8m) | ($24.1m) | $9.7m | ($399k) | |
| Increase (Decrease) in Accounts Payable | ($813k) | $1.5m | ($391k) | $905k | ($88.0m) | $1.2m | $1.9m | ($4.2m) | ($10.4m) | $11.5m | |
| Proceeds from Stock Options Exercised | $2.5m | $10.8m | $31.3m | $33.3m | $54.3m | $25.8m | $5.9m | $1.5m | $3.6m | $85k | |
| Accretion Expense | $262k | $6.4m | — | — | — | — | — | — | — | — | |
| Foreign Currency Transaction Gain (Loss), Realized | — | ($100k) | $100k | $200k | ($600k) | — | — | — | — | — | |
| General and Administrative Expense | $48.6m | $79.8m | $116.9m | $157.7m | $497.8m | $438.0m | $449.9m | $464.7m | $435.5m | $431.9m | |
| Goodwill | $188.2m | $498.5m | $737.2m | $746.1m | $14.6b | $14.5b | $1.1b | $1.1b | $283.2m | $283.2m | |
| Investment Income, Interest | — | — | — | — | — | — | — | $46.8m | $57.1m | $36.8m | |
| Realized Investment Gains (Losses) | — | — | — | — | — | $5.9m | $0 | $0 | — | — | |
| Restructuring Costs | — | — | — | — | — | — | $7.4m | $16.9m | $20.4m | $18.8m | |
| Revenue from Contract with Customer, Including Assessed Tax | — | — | $417.9m | $553.3m | $1.1b | $2.0b | — | — | — | — | |
| Net Cash Provided by (Used in) Operating Activities | ($51.9m) | ($34.4m) | ($4.9m) | $29.9m | ($53.5m) | $194.0m | $189.3m | $350.0m | $293.7m | $294.4m | |
| Cash flows from investing activities: | |||||||||||
| Payments to Acquire Property, Plant, and Equipment | $2.1m | $2.6m | $4.0m | $3.5m | $4.0m | $8.5m | $16.5m | $11.5m | $10.8m | $8.9m | |
| Payments to Acquire Businesses, Net of Cash Acquired | $37.0m | $379.4m | $282.4m | $11.2m | $567.4m | $78.7m | $0 | $0 | — | $81.9m | |
| Payments to Acquire Investments | — | — | — | — | — | — | — | — | — | $27.9m | |
| Payments for (Proceeds from) Other Investing Activities | — | — | — | — | — | ($8.7m) | ($2.5m) | ($1k) | $0 | ($60k) | |
| Net Cash Provided by (Used in) Investing Activities | $26.1m | ($448.4m) | ($257.5m) | $25.0m | ($591.0m) | ($73.0m) | ($167.7m) | ($156.3m) | ($124.1m) | ($266.0m) | |
| Cash flows from financing activities: | |||||||||||
| Proceeds from Issuance of Long-term Debt | $35.0m | $166.7m | $10k | — | — | — | — | — | — | — | |
| Repayments of Long-term Debt | $17.2m | $226.4m | — | $0 | — | — | — | — | — | — | |
| Proceeds from Issuance of Common Stock | $250k | $258.6m | $330.8m | $0 | $0 | — | — | — | — | — | |
| Proceeds from (Payments for) Other Financing Activities | — | — | — | — | — | ($4.2m) | ($2.9m) | $0 | ($2k) | $0 | |
| Net Cash Provided by (Used in) Financing Activities | $20.6m | $475.4m | $645.6m | $35.1m | $859.1m | $40.9m | $6.5m | $10.9m | $8.3m | ($551.7m) | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | $191k | ($2.1m) | $388k | $4.3m | ($1.8m) | ($3.3m) | $965k | ($3.3m) | $6.1m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | $514.4m | $733.3m | $893.5m | $918.2m | $1.1b | $1.3b | $781.1m | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Income Taxes Paid, Net | — | $137k | $441k | $1.3m | $1.3m | $4.0m | $2.5m | $7.2m | $8.9m | $8.7m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.